185 filings
Page 8 of 10
6-K
7uwb5jjl1jcg98c 87c
4 May 21
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
6:05am
6-K
frnv okat
28 Apr 21
Innate Pharma Files Its 2020 Universal Registration Document (Document D’enregistrement Universel) and 2020 Annual Report on Form 20-F
6:30am
6-K
jdwa fe5yjl40
21 Apr 21
The Annual General Meeting will be broadcasted live by the Company
6:30am
6-K
e2h2 xb1cgxo
21 Apr 21
Current report (foreign)
6:30am
6-K
twazu 91841h
19 Apr 21
Current report (foreign)
6:30am
6-K
usse0euiykno11h v8j
18 Mar 21
Innate Pharma Reports Full Year 2020 Financial(1) Results and Business Update
6:30am
6-K
uzt6gvor6ek49fzp8e
16 Mar 21
Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial Results
6:30am
6-K
vi8wq2
24 Feb 21
Current report (foreign)
6:30am
6-K
z5v8ijt1o zj
17 Feb 21
Innate Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
6:30am
6-K
24ftu 0vus
9 Feb 21
Innate Pharma Advances Lacutamab Clinical Development Program
6:30am
6-K
7pay 2z80
4 Feb 21
Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas
8:59am
6-K
0ef23b7
5 Jan 21
Innate’s First NK Cell Engager Selected by Sanofi as Drug Candidate for Development
6:30am
6-K
xhut j1hfrhkl8s4gbe2
4 Jan 21
Innate Pharma to Participate in Upcoming Investor Conferences
6:30am
6-K
cp7axm7 vhjep
11 Dec 20
Current report (foreign)
6:30am
6-K
ro5xutjj33o250x71s
3 Dec 20
Current report (foreign)
8:57am
6-K
4yzfyw486q3h1
2 Dec 20
Current report (foreign)
6:30am
6-K
fkr2md7831op4grp 5pu
17 Nov 20
Innate Pharma Reports Third Quarter 2020 Financial Results and Business Update
6:30am
6-K
43wlc0c5qrgwrdxhwner
13 Nov 20
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome
6:30am
6-K
xuisbggla
12 Nov 20
Innate Pharma to Participate in upcoming investor conferences
6:30am
6-K
5x12ib xkktcuyo97k7
5 Nov 20
Current report (foreign)
8:00am